12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers MyMD Pharmaceuticals (NASDAQ:MYMD) stock rose 11.9% to $2.25 during Friday’s after-market session. The market value of their…
Renalytix Completes Agreement With Veterans Administration To Integrate Kidneyintelx Testing Across All Electronic Health Record Systems
Renalytix plc (NASDAQ:RNLX) (LSE: RENX) today announced the execution of a Co-operative Research and Development Agreement (CRADA) with the U.S. Veterans Health Administration Innovation Ecosystem (VHA IE) to install the
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Invacare (NYSE:IVC) stock rose 14.3% to $0.48 during Friday’s after-market session. The market value of their outstanding…
HC Wainwright & Co. Maintains Buy on Renalytix, Lowers Price Target to $8
HC Wainwright & Co. analyst Yi Chen maintains Renalytix (NASDAQ:RNLX) with a Buy and lowers the price target from $10 to $8.
Renalytix AI Q1 EPS $(0.16) Misses $(0.13) Estimate, Sales $969.00K Miss $1.10M Estimate
Renalytix AI (NASDAQ:RNLX) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 14.29 percent decrease over losses of $(0.14) per share from
Earnings Scheduled For November 30, 2022
Companies Reporting Before The Bell
• Seadrill (NYSE:SDRL) is expected to report earnings for its third quarter.
• Build-A-Bear Workshop (NYSE:BBW) is likely to report earnings for its third quarter.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Otonomy (NASDAQ:OTIC) shares increased by 114.7% to $0.23 during Tuesday’s regular session. The current volume of 184.8…
Preview: Renalytix AI’s Earnings
Renalytix AI (NASDAQ:RNLX) is set to give its latest quarterly earnings report on Wednesday, 2022-11-30. Here’s what investors…
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product candidates.
